| Characteristics and Measures* . | All Subjects (N = 90) . |
|---|---|
| Time on Steroids after Procedure, days | N = 79 |
| Mean (SD) | 62.1 (166.8) |
| Median, (Min, Max) | 13 (0.0, 1229.0) |
| Time from LITT to start of Chemotherapy, days | N = 32 |
| Mean (SD) | 154.9 ± 153.3 |
| Median, (Min, Max) | 91 (1.0, 488) |
| Never stopped chemotherapy, No. (%) | 11/27 (40.7) |
| Time from LITT to start of Immunotherapy, days | N = 9 |
| Mean (SD) | 388.1 (383.4) |
| Median, (Min, Max) | 302 (43, 1330) |
| Never stopped immunotherapy | 3/17 (17.6) |
| Characteristics and Measures* . | All Subjects (N = 90) . |
|---|---|
| Time on Steroids after Procedure, days | N = 79 |
| Mean (SD) | 62.1 (166.8) |
| Median, (Min, Max) | 13 (0.0, 1229.0) |
| Time from LITT to start of Chemotherapy, days | N = 32 |
| Mean (SD) | 154.9 ± 153.3 |
| Median, (Min, Max) | 91 (1.0, 488) |
| Never stopped chemotherapy, No. (%) | 11/27 (40.7) |
| Time from LITT to start of Immunotherapy, days | N = 9 |
| Mean (SD) | 388.1 (383.4) |
| Median, (Min, Max) | 302 (43, 1330) |
| Never stopped immunotherapy | 3/17 (17.6) |
*Baseline steroid use includes patients who were started on steroids within 6 weeks before or 2 weeks after Laser interstitial thermal therapy (LITT) procedure. Chemotherapy and immunotherapy baseline use was defined as therapy delivered within three months prior to the LITT procedure.
| Characteristics and Measures* . | All Subjects (N = 90) . |
|---|---|
| Time on Steroids after Procedure, days | N = 79 |
| Mean (SD) | 62.1 (166.8) |
| Median, (Min, Max) | 13 (0.0, 1229.0) |
| Time from LITT to start of Chemotherapy, days | N = 32 |
| Mean (SD) | 154.9 ± 153.3 |
| Median, (Min, Max) | 91 (1.0, 488) |
| Never stopped chemotherapy, No. (%) | 11/27 (40.7) |
| Time from LITT to start of Immunotherapy, days | N = 9 |
| Mean (SD) | 388.1 (383.4) |
| Median, (Min, Max) | 302 (43, 1330) |
| Never stopped immunotherapy | 3/17 (17.6) |
| Characteristics and Measures* . | All Subjects (N = 90) . |
|---|---|
| Time on Steroids after Procedure, days | N = 79 |
| Mean (SD) | 62.1 (166.8) |
| Median, (Min, Max) | 13 (0.0, 1229.0) |
| Time from LITT to start of Chemotherapy, days | N = 32 |
| Mean (SD) | 154.9 ± 153.3 |
| Median, (Min, Max) | 91 (1.0, 488) |
| Never stopped chemotherapy, No. (%) | 11/27 (40.7) |
| Time from LITT to start of Immunotherapy, days | N = 9 |
| Mean (SD) | 388.1 (383.4) |
| Median, (Min, Max) | 302 (43, 1330) |
| Never stopped immunotherapy | 3/17 (17.6) |
*Baseline steroid use includes patients who were started on steroids within 6 weeks before or 2 weeks after Laser interstitial thermal therapy (LITT) procedure. Chemotherapy and immunotherapy baseline use was defined as therapy delivered within three months prior to the LITT procedure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
